Celularity (CELUW) Depreciation & Amortization (CF) (2020 - 2025)
Celularity (CELUW) reported Depreciation & Amortization (CF) of $1.8 million for Q4 2025, down 3.89% year-over-year from $1.9 million in Q4 2024, and down 1.15% quarter-over-quarter from $1.8 million in Q3 2025.
Celularity (CELUW) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $1.8 million in Q4 2025.
- Depreciation & Amortization (CF) for Q4 2025 came in at $1.8 million, down 3.89% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.3 million (down 7.91% YoY), and the FY2025 annual result was $7.3 million, down 7.91% from the prior year.
- Depreciation & Amortization (CF) slipped to $1.8 million in Q4 2025 per CELUW's latest filing, from $1.8 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $2.6 million in Q4 2021 and troughed at $1.8 million in Q4 2025.
- A 5-year average of $2.1 million and a median of $2.2 million in 2022 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2021 and 2024: Depreciation & Amortization (CF) surged 55.03% in 2021, then decreased 19.16% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.6 million in 2021, then fell by 6.41% to $2.4 million in 2022, then declined by 5.86% to $2.3 million in 2023, then retreated by 18.29% to $1.9 million in 2024, then decreased by 3.89% to $1.8 million in 2025.
- Business Quant data shows CELUW's Depreciation & Amortization (CF) at $1.8 million in Q4 2025, $1.8 million in Q3 2025, and $1.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Celularity | - | - | -3.27 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.80 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 2.34 Mn |
| Sep 30, 2023 | 2.34 Mn |